SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-048284
Filing Date
2009-08-07
Accepted
2009-08-07 17:03:22
Documents
6
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09-18856_110q.htm 10-Q 868704
2 EX-10.3 a09-18856_1ex10d3.htm EX-10.3 26148
3 EX-31.1 a09-18856_1ex31d1.htm EX-31.1 11421
4 EX-31.2 a09-18856_1ex31d2.htm EX-31.2 11099
5 EX-32.1 a09-18856_1ex32d1.htm EX-32.1 5320
6 EX-32.2 a09-18856_1ex32d2.htm EX-32.2 5390
  Complete submission text file 0001104659-09-048284.txt   929611
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 09996599
SIC: 2836 Biological Products, (No Diagnostic Substances)